ICH M12 Guidelines & Your Drug-Drug Interaction Package
We have provided an overview of the key changes to the ICH M12 drug-drug interaction…
CertaraJune 19, 2024
Case Study. Enhancing HEOR Global Knowledge Sharing
The Global Health Economics and Outcomes Research (HEOR) team of a leading global healthcare company…
CertaraJune 19, 2024
How a top 10 pharma fought the rising tide of non-CRF data
Discover how a top pharma company used Pinnacle 21 Data Exchange to automate non-CRF data…
CertaraJune 17, 2024
Joint Clinical Assessment (JCA) And Potential Consequences For The Evaluation Of Gene Therapies
In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…
CertaraJune 17, 2024
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies RADNOR, PA…
CertaraJune 17, 2024
Using Real World Data in Clinical Trial Submissions
We explore challenges & best practice recommendations to help you implement submission standards when using…
CertaraJune 17, 2024
Introducing CoAuthor™: The Gen-AI Enabled Solution for Regulatory Writers
Faced with more (and more complex) clinical research than ever before, regulatory writers are facing…
CertaraJune 14, 2024
Certara Recognized as a Top Biopharma Workplace for 2024
RADNOR, PA – June 12, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraJune 12, 2024
